{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:32:10Z","timestamp":1788460330599,"version":"build-2803163510"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["P50MH122379"],"award-info":[{"award-number":["P50MH122379"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["R01MH128235"],"award-info":[{"award-number":["R01MH128235"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience &amp; Biobehavioral Reviews"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.neubiorev.2023.105327","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T04:20:33Z","timestamp":1690258833000},"page":"105327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Neurosteroid influence on affective tone"],"prefix":"10.1016","volume":"152","author":[{"given":"Najah L.","family":"Walton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Antonoudiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.neubiorev.2023.105327_bib1","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1073\/pnas.1403285111","article-title":"Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors","volume":"111","author":"Abramian","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"39","key":"10.1016\/j.neubiorev.2023.105327_bib2","doi-asserted-by":"crossref","first-page":"14602","DOI":"10.1073\/pnas.0606544103","article-title":"Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis","volume":"103","author":"Ag\u00eds-Balboa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2023.105327_bib3","article-title":"Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice","volume":"Vol. 104","author":"Ag\u00eds-Balboa","year":"2007"},{"issue":"17","key":"10.1016\/j.neubiorev.2023.105327_bib4","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1007\/s00213-014-3567-5","article-title":"5\u03b1-reductase type I expression is downregulated in the prefrontal cortex\/Brodmann\u2019s area 9 (BA9) of depressed patients","volume":"231","author":"Ag\u00eds-Balboa","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2023.105327_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jpsychires.2023.04.003","article-title":"Morning salivary dehydroepiandrosterone (DHEA) qualifies as the only neuroendocrine biomarker separating depressed patients with and without prior history of depression: An HPA axis challenge study","volume":"161","author":"Agorastos","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"50","key":"10.1016\/j.neubiorev.2023.105327_bib6","doi-asserted-by":"crossref","first-page":"11605","DOI":"10.1523\/JNEUROSCI.4173-05.2005","article-title":"Neurosteroid Access to the GABAA Receptor","volume":"25","author":"Akk","year":"2005","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib7","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1124\/mol.108.048520","article-title":"Mutations of the GABA-A Receptor \u03b11 Subunit M1 Domain Reveal Unexpected Complexity for Modulation by Neuroactive Steroids","volume":"74","author":"Akk","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2023.105327_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115495","article-title":"The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD","volume":"22","author":"Almeida","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neubiorev.2023.105327_bib9","first-page":"181","article-title":"Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator","author":"Althaus","year":"2020","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biopsych.2021.07.017","article-title":"Allopregnanolone mediates affective switching through modulation of oscillatory states in the basolateral amygdala","volume":"91","author":"Antonoudiou","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jad.2021.02.027","article-title":"Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder","volume":"285","author":"Arnaud","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2023.105327_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/FBP.0000000000000467","article-title":"Animal models of post-traumatic stress disorder and novel treatment targets","author":"Aspesi","year":"2019","journal-title":"Behav. Pharmacol., 30(2and3-Spec. )"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37409-6","article-title":"endogenous Neurosteroid (3\u03b1,5\u03b1)3-Hydroxypregnan-20-one Inhibits Toll-like-4 Receptor Activation and Pro-inflammatory Signaling in Macrophages and Brain","volume":"9","author":"Balan","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neubiorev.2023.105327_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104473","article-title":"Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways","volume":"89","author":"Balan","year":"2023","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105327_bib16","first-page":"565","article-title":"Neurosteroids: Endogenous regulators of the GABAA receptor","volume":"Vol. 6","author":"Belelli","year":"2005"},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2008-1982","article-title":"Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial","volume":"94","author":"Binder","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002130000472","article-title":"The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat","volume":"151","author":"Bitran","year":"2000","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0091-3057(93)90260-Z","article-title":"Anxiolytic effect of progesterone is associated with increases in cortical alloprenanolone and GABAA receptor function","volume":"45","author":"Bitran","year":"1993","journal-title":"Pharmacol., Biochem. Behav."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2023.105327_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.psychres.2012.07.012","article-title":"Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study","volume":"200","author":"Bloch","year":"2012","journal-title":"Psychiatry Res."},{"issue":"13","key":"10.1016\/j.neubiorev.2023.105327_bib21","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1038\/npp.2008.39","article-title":"Antipsychotic-like properties of 5-alpha-reductase inhibitors","volume":"33","author":"Bortolato","year":"2008","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-1781(03)00077-5","article-title":"Neurosteroid secretion in panic disorder","volume":"118","author":"Brambilla","year":"2003","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neubiorev.2023.105327_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/7854_2018_53","article-title":"Neuroimmune impacts of early-life stress on development and psychopathology","volume":"43","author":"Brenhouse","year":"2019","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)00096-4","article-title":"The anxiolytic-like effects of the neurosteroid allopregnanolone: Interactions with GABA(A) receptors","volume":"325","author":"Brot","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.neubiorev.2023.105327_bib25","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/npp.2014.138","article-title":"A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression","volume":"39","author":"Brown","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"10154","key":"10.1016\/j.neubiorev.2023.105327_bib26","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0140-6736(18)32356-0","article-title":"Inflamed depression","volume":"392","author":"Bullmore","year":"2018","journal-title":"Lancet"},{"issue":"73","key":"10.1016\/j.neubiorev.2023.105327_bib27","article-title":"Neurosteroids in schizophrenia: pathogenic and therapeutic implications","volume":"9","author":"Cai","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-9081-8-61","article-title":"GABAergic neuroactive steroids: A new frontier in bipolar disorders?","volume":"8","author":"Carta","year":"2012","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.neubiorev.2023.105327_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jsbmb.2014.03.012","article-title":"Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma","volume":"146","author":"Caruso","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib30","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA A receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacol. (Berl. )"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.115.229302","article-title":"Neurosteroid structure-activity relationships for functional activation of extrasynaptic \u03b4GABAA receptors","volume":"357","author":"Carver","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neubiorev.2023.105327_bib32","article-title":"2017 National Survey on Drug Use and Health","author":"Center for Behavioral Health Statistics","year":"2017","journal-title":"Methodol. Summ. D\u00e9fin."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000157","article-title":"Multiple functional neurosteroid binding sites on gabaa receptors","volume":"17","author":"Chen","year":"2019","journal-title":"PLoS Biol."},{"issue":"11","key":"10.1016\/j.neubiorev.2023.105327_bib34","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.psyneuen.2013.07.007","article-title":"Bipolar Disorder is associated with the rs6971 polymorphism in the gene encoding 18 kDa Translocator Protein (TSPO)","volume":"38","author":"Colasanti","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib35","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/endo.136.6.7750493","article-title":"Expression of the steroidogenic enzyme P450scc in the central and peripheral nervous systems during rodent embryogenesis","volume":"136","author":"Compagnone","year":"1995","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.neubiorev.2023.105327_bib36","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"12","key":"10.1016\/j.neubiorev.2023.105327_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123472","article-title":"Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms","volume":"10","author":"Danek","year":"2021","journal-title":"Cells"},{"issue":"21","key":"10.1016\/j.neubiorev.2023.105327_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213513","article-title":"The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia","volume":"11","author":"Danek","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.neubiorev.2023.105327_bib39","first-page":"151","article-title":"Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects","author":"Danek","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neubiorev.2023.105327_bib40","article-title":"Neurosteroids reverse tonic inhibitory deficits in Fragile X syndrome mouse model","author":"Davies","year":"2017","journal-title":"FASEB J., 31(S1), 815. 12-815. 12"},{"issue":"8","key":"10.1016\/j.neubiorev.2023.105327_bib41","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/j.1476-5381.2011.01733.x","article-title":"Role of neurosteroids in the anticonvulsant activity of midazolam","volume":"165","author":"Dhir","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105327_bib42","first-page":"325","article-title":"Neurosteroid perturbation and neuropsychiatric symptoms in schizophrenia: From the mechanisms to the treatment. Neuroactive Steroids in Brain Function","author":"Di Michele","year":"2008","journal-title":"Behav. Neuropsychiatr. Disord.: Nov. Strateg. Res. Treat."},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib43","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.4088\/JCP.19m12887","article-title":"Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study","volume":"81","author":"Dichtel","year":"2020","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib44","first-page":"12","article-title":"Post-finasteride syndrome: An emerging clinical problem","author":"Diviccaro","year":"2019","journal-title":"Neurobiol. Stress"},{"issue":"11","key":"10.1016\/j.neubiorev.2023.105327_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111567","article-title":"Gut inflammation induced by finasteride withdrawal: therapeutic effect of allopregnanolone in adult male rats","volume":"12","author":"Diviccaro","year":"2022","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.neubiorev.2023.105327_bib46","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1073\/pnas.051628598","article-title":"Brain 5\u03b1-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation","volume":"98","author":"Dong","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neubiorev.2023.105327_bib47","first-page":"11","article-title":"Allopregnanolone decreases evoked dopamine release differently in rats by sex and estrous stage","author":"Dornellas","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib48","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1038\/s41467-020-17825-x","article-title":"Circuit-specific hippocampal \u0394FosB underlies resilience to stress-induced social avoidance","volume":"11","author":"Eagle","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neubiorev.2023.105327_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jad.2022.09.143","article-title":"Effect of brexanolone on depressive symptoms, anxiety, and insomnia in women with postpartum depression: Pooled analyses from 3 double-blind, randomized, placebo-controlled clinical trials in the HUMMINGBIRD clinical program","volume":"320","author":"Epperson","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neubiorev.2023.105327_bib50","article-title":"VizHub - GBD Compare","author":"Evaluation, I. for H. M. and","year":"2019","journal-title":"GBD Comp. Hub."},{"issue":"8","key":"10.1016\/j.neubiorev.2023.105327_bib51","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.neuropharm.2012.08.012","article-title":"Allopregnanolone regulates neurogenesis and depressive\/anxiety-like behaviour in a social isolation rodent model of chronic stress","volume":"63","author":"Evans","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2023.105327_bib52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2018.09.018","article-title":"5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction","volume":"121","author":"Fanni","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"7488","key":"10.1016\/j.neubiorev.2023.105327_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bmj.330.7488.396","article-title":"Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials","volume":"330","author":"Fergusson","year":"2005","journal-title":"BMJ (Clin. Res. Ed. )"},{"key":"10.1016\/j.neubiorev.2023.105327_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainresbull.2022.01.020","article-title":"The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting","volume":"181","author":"Floris","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib55","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.neubiorev.2008.03.003","article-title":"Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders","volume":"32","author":"Fone","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant Drug effects and Depression Severity: A Patient-Level Meta-Analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib57","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.psyneuen.2013.09.014","article-title":"Inhibition of 17\u03b1-hydroxylase\/C17,20 lyase reduces gating deficits consequent to dopaminergic activation","volume":"39","author":"Frau","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/hbeh.2002.1763","article-title":"Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats","volume":"41","author":"Frye","year":"2002","journal-title":"Horm. Behav."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2023.105327_bib59","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2004.01.020","article-title":"Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5\u03b1-reductase","volume":"1004","author":"Frye","year":"2004","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib60","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1177\/1557988314538445","article-title":"Persistent sexual, emotional, and cognitive impairment post-finasteride","volume":"9","author":"Ganzer","year":"2014","journal-title":"Am. J. Men\u2019s Health"},{"issue":"10","key":"10.1016\/j.neubiorev.2023.105327_bib61","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0006-3223(94)91139-8","article-title":"CSF neuroactive steroids in affective disorders: Pregnenolone, progesterone, and DBI","volume":"35","author":"George","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib62","article-title":"GABAA receptors: structure, function, pharmacology, and related disorders","author":"Ghit","year":"2021","journal-title":"J. Genet. Eng. Biotechnol. 2021 19:1, 19(1), 1\u201315"},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib63","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1159\/000442982","article-title":"Effects of Subchronic Finasteride Treatment and Withdrawal on Neuroactive Steroid Levels and Their Receptors in the Male Rat Brain","volume":"103","author":"Giatti","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neubiorev.2023.105327_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.802530","article-title":"GABA system modifications during periods of hormonal flux across the female lifespan","volume":"16","author":"Gilfarb","year":"2022","journal-title":"Front. Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajmg.b.32147","article-title":"Sex dependent influence of a functional polymorphism in steroid 5-\u03b1-reductase type 2 (SRD5A2) on post-traumatic stress symptoms","volume":"162","author":"Gillespie","year":"2013","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatr. Genet."},{"issue":"23","key":"10.1016\/j.neubiorev.2023.105327_bib66","doi-asserted-by":"crossref","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2023.105327_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-0173(01)00129-1","article-title":"The socially-isolated mouse: A model to study the putative role of allopregnanolone and 5\u03b1-dihydroprogesterone in psychiatric disorders","volume":"37","author":"Guidotti","year":"2001","journal-title":"Brain Res. Rev."},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105327_bib68","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0006-3223(98)00070-5","article-title":"Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3\u03b1, 5\u03b1- tetrahydroprogesterone (allopregnanolone) availability","volume":"44","author":"Guidotti","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.neubiorev.2023.105327_bib69","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1815981","article-title":"Trial of SAGE-217 in Patients with Major Depressive Disorder","volume":"381","author":"Gunduz-Bruce","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2023.105327_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2010.10.077","article-title":"The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain","volume":"651","author":"Haduch","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol., Neurosurg., Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib72","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","article-title":"Suicidality in Pediatric Patients Treated With Antidepressant Drugs","volume":"63","author":"Hammad","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib73","doi-asserted-by":"crossref","unstructured":"Healy, D., & Aldred, G., 2009, Antidepressant drug use & the risk of suicide. Http:\/\/Dx.Doi.Org\/10.1080\/09540260500071624, 17(3), 163\u2013172. https:\/\/doi.org\/10.1080\/09540260500071624.","DOI":"10.1080\/09540260500071624"},{"issue":"suppl 6","key":"10.1016\/j.neubiorev.2023.105327_bib74","first-page":"8272","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"7118","key":"10.1016\/j.neubiorev.2023.105327_bib75","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib76","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The Dopamine Hypothesis of Schizophrenia: Version III-The Final Common Pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41380-021-01200-3","article-title":"Treatment resistance in psychiatry: state of the art and new directions","volume":"27","author":"Howes","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105327_bib78","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4088\/JCP.12m07887","article-title":"Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects","volume":"73","author":"Irwig","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"10159","key":"10.1016\/j.neubiorev.2023.105327_bib79","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.neubiorev.2023.105327_bib80","first-page":"359","article-title":"Effects of some centrally active drugs on the allopregnanolone synthesis in rat brain","volume":"52","author":"Jaworska-Feil","year":"2000","journal-title":"Pol. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.neubiorev.2023.105327_bib81","article-title":"Antidepressants and the risk of suicidal behaviors","volume":"292","author":"Jick","year":"2004","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2023.105327_bib82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jad.2011.04.009","article-title":"AKR1C4 gene variant associated with low euthymic serum progesterone and a history of mood irritability in males with bipolar disorder","volume":"133","author":"Johansson","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105327_bib83","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.euroneuro.2012.01.007","article-title":"Polymorphisms in AKR1C4 and HSD3B2 and differences in serum DHEAS and progesterone are associated with paranoid ideation during mania or hypomania in bipolar disorder","volume":"22","author":"Johansson","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"Issue 11","key":"10.1016\/j.neubiorev.2023.105327_bib84","article-title":"Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. In","volume":"Vol. 163","author":"John Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"10093","key":"10.1016\/j.neubiorev.2023.105327_bib85","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","article-title":"Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial","volume":"390","author":"Kanes","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2576","article-title":"Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression","volume":"32","author":"Kanes","year":"2017","journal-title":"Hum. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib87","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0006-8993(00)02373-8","article-title":"Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice","volume":"865","author":"Khisti","year":"2000","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib88","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0091-3057(00)00300-2","article-title":"Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test","volume":"67","author":"Khisti","year":"2000","journal-title":"Pharmacol., Biochem., Behav."},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib89","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1550059420909676","article-title":"Serum Neurosteroid Levels Are Associated With Cortical Thickness in Individuals Diagnosed With Posttraumatic Stress Disorder and History of Mild Traumatic Brain Injury","volume":"51","author":"Kinzel","year":"2020","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105327_bib90","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.schres.2017.02.001","article-title":"Effect of psychotropic drug treatment on sterol metabolism","volume":"187","author":"Korade","year":"2017","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib91","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1159\/000126405","article-title":"During Anesthetic-Induced Activation of Hypothalamic Pituitary Adrenal Axis, Blood-Borne Steroids Fail to Contribute to the Anesthetic Effect","volume":"57","author":"Korneyev","year":"1993","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3371\/CSRP.KRBA.013114","article-title":"Adjunctive pregnenolone ameliorates the cognitive deficits in recent-onset schizophrenia: An 8-week, randomized, double-blind, placebo-controlled trial","volume":"10","author":"Kreinin","year":"2017","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.neubiorev.2023.105327_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/j.1369-1600.2008.00106.x","article-title":"Cannabis and psychiatric disorders: it is not only addiction","author":"Leweke","year":"2008","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib94","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.3892\/mmr.2015.4712","article-title":"Selective regulation of neurosteroid biosynthesis under ketamine-induced apoptosis of cortical neurons in vitro","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cns.12781","article-title":"Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats","volume":"24","author":"Li","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neubiorev.2023.105327_bib96","doi-asserted-by":"crossref","DOI":"10.1177\/2470547018818555","article-title":"Overview of the Molecular Steps in Steroidogenesis of the GABAergic Neurosteroids Allopregnanolone and Pregnanolone","volume":"2","author":"Liang","year":"2018","journal-title":"Chronic Stress"},{"key":"10.1016\/j.neubiorev.2023.105327_bib97","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.schres.2020.03.022","article-title":"Aberrant posterior cingulate connectivity classify first-episode schizophrenia from controls: A machine learning study","volume":"220","author":"Liang","year":"2020","journal-title":"Schizophr. Res."},{"issue":"SEP","key":"10.1016\/j.neubiorev.2023.105327_bib98","first-page":"309","article-title":"Toll-like receptor 4: Innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder","volume":"8","author":"Liu","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105327_bib99","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pnpbp.2018.12.014","article-title":"Social isolation as a promising animal model of PTSD comorbid suicide: neurosteroids and cannabinoids as possible treatment options","volume":"92","author":"Locci","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2023.105327_bib100","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopsych.2019.02.006","article-title":"Stimulation of Peroxisome Proliferator-Activated Receptor-\u03b1 by N-Palmitoylethanolamine Engages Allopregnanolone Biosynthesis to Modulate Emotional Behavior","volume":"85","author":"Locci","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib101","article-title":"The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis","volume":"10","author":"Luc Do Rego","year":"2015","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib102","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"L\u00fcscher","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib103","doi-asserted-by":"crossref","first-page":"751","DOI":"10.12688\/f1000research.18758.1","article-title":"Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience [version 1; peer review: 4 approved]","volume":"8","author":"L\u00fcscher","year":"2019","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib104","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1461145703003821","article-title":"Chronic lithium treatment affects rat brain and serum dehydroepiandrosterone (DHEA) and DHEA-sulphate (DHEA-S) levels","volume":"7","author":"Maayan","year":"2004","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105327_bib105","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1523\/JNEUROSCI.4945-06.2007","article-title":"Neurosteroid Synthesis-Mediated Regulation of GABAA Receptors: Relevance to the Ovarian Cycle and Stress","volume":"27","author":"Maguire","year":"2007","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib106","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nn1469","article-title":"Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizure susceptibility and anxiety","volume":"8","author":"Maguire","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib107","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0188-0128(99)00024-X","article-title":"Progesterone reduces immobility in rats forced to swim","volume":"30","author":"Mart\u00ednez-Mota","year":"1999","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neubiorev.2023.105327_bib108","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.biopsych.2018.02.056","article-title":"39. Biomarkers and New Therapeutics in PTSD and TBI: Neurosteroid Signatures to Randomized Controlled Trials","volume":"83","author":"Marx","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"suppl_1","key":"10.1016\/j.neubiorev.2023.105327_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbx021.038","article-title":"19. Randomized Controlled Trial of a Neurosteroid Intervention in Schizophrenia","volume":"43","author":"Marx","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.npp.1300015","article-title":"Olanzapine and Clozapine Increase the GABAergic Neuroactive Steroid Allopregnanolone in Rodents","volume":"28","author":"Marx","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib111","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pbb.2006.07.026","article-title":"Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol., Biochem., Behav."},{"key":"10.1016\/j.neubiorev.2023.105327_bib112","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and Therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib113","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S1461145708008444","article-title":"Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice","volume":"11","author":"Marx","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.neubiorev.2023.105327_bib114","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/npp.2009.26","article-title":"Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia","volume":"34","author":"Marx","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib115","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0000000000000793","article-title":"Neurosteroid Levels in Patients with Bipolar Disorder and a History of Cannabis Use Disorders","volume":"37","author":"Mason","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neubiorev.2023.105327_bib116","article-title":"GABA A receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: Possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders","author":"Matsumoto","year":"2009","journal-title":"Stress Int. J. Biol. Stress"},{"issue":"10","key":"10.1016\/j.neubiorev.2023.105327_bib117","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1111\/jsm.12269","article-title":"Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post-Finasteride Patients Showing Persistent Sexual Side Effects and Anxious\/Depressive Symptomatology","volume":"10","author":"Melcangi","year":"2013","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.neubiorev.2023.105327_bib118","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsbmb.2017.04.003","article-title":"Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients","volume":"171","author":"Melcangi","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib119","first-page":"173","article-title":"Synthesis and Actions of 5\u03b1-Reduced Metabolites of Testosterone in the Nervous System","volume":"2","author":"Melcangi","year":"2021","journal-title":"Androgens"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2007.04.011","article-title":"Neurosteroid regulation of CNS development","volume":"116","author":"Mellon","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib121","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1081\/ERC-120016823","article-title":"Synthesis, regulation, and function of neurosteroids","volume":"28","author":"Mellon","year":"2002","journal-title":"Endocr. Res."},{"issue":"10152","key":"10.1016\/j.neubiorev.2023.105327_bib122","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2023.105327_bib123","first-page":"3","article-title":"GABAA receptors: Properties and trafficking","volume":"Vol. 42","author":"Michels","year":"2007"},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2023.105327_bib124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2004.02.011","article-title":"Volume of the cingulate and outcome in schizophrenia","volume":"72","author":"Mitelman","year":"2005","journal-title":"Schizophr. Res."},{"issue":"May","key":"10.1016\/j.neubiorev.2023.105327_bib125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuropharm.2016.10.010","article-title":"Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism","volume":"113","author":"Modgil","year":"2017","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105327_bib126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tins.2004.07.002","article-title":"Diversity of inhibitory neurotransmission through GABA(A) receptors","volume":"27","author":"Mody","year":"2004","journal-title":"Trends Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib127","first-page":"1360","article-title":"Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age","volume":"78","author":"Morales","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.110.069542","article-title":"Different Residues in the GABAA Receptor Benzodiazepine Binding Pocket Mediate Benzodiazepine Efficacy and Binding","volume":"80","author":"Morlock","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neubiorev.2023.105327_bib129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.psyneuen.2019.06.009","article-title":"Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation","volume":"108","author":"Mosher","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.0.1490583","article-title":"Endogenous sex hormones in men aged 40-80 years","volume":"149","author":"Muller","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neubiorev.2023.105327_bib131","first-page":"97","article-title":"Regulation of GABAARs by phosphorylation","volume":"Vol. 72","author":"Nakamura","year":"2015"},{"key":"10.1016\/j.neubiorev.2023.105327_bib132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/7539065","article-title":"Impaired Functional Connectivity in the Prefrontal Cortex: A Mechanism for Chronic Stress-Induced Neuropsychiatric Disorders","volume":"2016","author":"Negr\u00f3n-Oyarzo","year":"2016","journal-title":"Neural Plast."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2023.105327_bib133","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.schres.2004.04.009","article-title":"NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI","volume":"72","author":"Northoff","year":"2005","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib134","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138161211795049589","article-title":"Steroid 5\u03b1-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders","volume":"17","author":"Paba","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neubiorev.2023.105327_bib135","doi-asserted-by":"crossref","unstructured":"Pang, Y., Dong, J., & Thomas, P., 2013, Characterization, Neurosteroid Binding and Brain Distribution of Human Membrane Progesterone Receptors and (mPR and mPR) and mPR Involvement in Neurosteroid Inhibition of Apoptosis. https:\/\/doi.org\/10.1210\/en.2012\u20131772.","DOI":"10.1210\/en.2012-1772"},{"issue":"32","key":"10.1016\/j.neubiorev.2023.105327_bib136","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.1074\/jbc.RA119.008875","article-title":"Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors","volume":"294","author":"Parakala","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib137","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/mol.52.6.1113","article-title":"Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids","volume":"52","author":"Park-Chung","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib138","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaclp.2021.08.001","article-title":"A brexanolone treatment program at an academic medical center: patient selection, 90-day posttreatment outcomes, and lessons learned","volume":"63","author":"Patterson","year":"2022","journal-title":"J. Acad. Consult. -Liaison Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib139","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jamapsychiatry.2020.2694","volume":"78","author":"Paus","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"14","key":"10.1016\/j.neubiorev.2023.105327_bib140","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0801853105","article-title":"Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder","volume":"105","author":"Pibiri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"AUG","key":"10.1016\/j.neubiorev.2023.105327_bib141","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fnins.2018.00482","article-title":"Biomarkers for PTSD at the interface of the endocannabinoid and neurosteroid axis","volume":"12","author":"Pinna","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105327_bib142","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fendo.2020.00236","article-title":"Allopregnanolone, the neuromodulator turned therapeutic agent: thank you, next?","volume":"11","author":"Pinna","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neubiorev.2023.105327_bib143","first-page":"4","article-title":"In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine","volume":"Vol. 18","author":"Pinna","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib144","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00427123","article-title":"The Geller-Seifter conflict paradigm with incremental shock","volume":"62","author":"Pollard","year":"1979","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jne.12351","article-title":"Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research","volume":"28","author":"Porcu","year":"2016","journal-title":"J. Neuroendocrinol."},{"issue":"5604","key":"10.1016\/j.neubiorev.2023.105327_bib146","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.neubiorev.2023.105327_bib147","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1073\/pnas.88.10.4553","article-title":"Stress-induced elevations of \u03b3-aminobutyric acid type a receptor-active steroids in the rat brain","volume":"88","author":"Purdy","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-6-7","article-title":"Finasteride induced depression: A prospective study","volume":"6","author":"Rahimi-Ardabili","year":"2006","journal-title":"BMC Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.neubiorev.2023.105327_bib149","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.biopsych.2006.03.026","article-title":"Decreased Cerebrospinal Fluid Allopregnanolone Levels in Women with Posttraumatic Stress Disorder","volume":"60","author":"Rasmusson","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib150","first-page":"2245","article-title":"A randomized controlled trial of ganaxolone in posttraumatic stress disorder","volume":"234","author":"Rasmusson","year":"2017"},{"key":"10.1016\/j.neubiorev.2023.105327_bib151","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.psyneuen.2018.11.027","article-title":"Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD","volume":"102","author":"Rasmusson","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib152","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13062","article-title":"A role for deficits in GABAergic neurosteroids and their metabolites with NMDA receptor antagonist activity in the pathophysiology of posttraumatic stress disorder","volume":"34","author":"Rasmusson","year":"2022","journal-title":"J. Neuroendocrinol."},{"issue":"8","key":"10.1016\/j.neubiorev.2023.105327_bib153","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neubiorev.2005.04.010","article-title":"Stress-induced enhancement of fear learning: An animal model of posttraumatic stress disorder","volume":"29","author":"Rau","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2023.105327_bib154","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.vh.2017.12.001","article-title":"GABA-A Receptors Mediate Tonic Inhibition and Neurosteroid Sensitivity in the Brain","volume":"107","author":"Reddy","year":"2018","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.neubiorev.2023.105327_bib155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-813814-4.00004-3","article-title":"Neurosteroids: Biosynthesis, Molecular Mechanisms, and Neurophysiological Functions in the Human Brain","author":"Reddy","year":"2020","journal-title":"Horm. Signal. Biol. Med.: Compr. Mod. Endocrinol."},{"issue":"5","key":"10.1016\/j.neubiorev.2023.105327_bib156","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nchembio.917","article-title":"Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands","volume":"8","author":"Richter","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib157","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1755-5949.2009.00118.x","article-title":"Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials","volume":"16","author":"Ritsner","year":"2010","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib158","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/pcn.12150","article-title":"Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial","volume":"68","author":"Ritsner","year":"2014","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"9","key":"10.1016\/j.neubiorev.2023.105327_bib159","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0166-2236(99)01399-5","article-title":"Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives","volume":"22","author":"Rupprecht","year":"1999","journal-title":"Trends Neurosci."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0896-6273(93)90156-L","article-title":"Progesterone receptor-mediated effects of neuroactive steroids","volume":"11","author":"Rupprecht","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neubiorev.2023.105327_bib161","unstructured":"Schmidt, P.J., Daly, R.C., Bloch, M., Smith, M.J., Danaceau, M.A., Simpson St Clair, L., Murphy, J.H., Haq, N., Rubinow, D.R., & Simpson St Clair, M., 1996, Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib162","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archpsyc.62.2.154","article-title":"Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression","volume":"62","author":"Schmidt","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib163","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.mp.4001782","article-title":"Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity","volume":"11","author":"Sch\u00fcle","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib164","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1176\/jnp.13.3.396","article-title":"CLINICAL AND RESEARCH REPORTS Neuroactive Steroid Levels in Patients With Generalized Anxiety Disorder","volume":"13","author":"Semeniuk","year":"2001","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2023.105327_bib165","doi-asserted-by":"crossref","unstructured":"Serra, M., Pisu, M.G., Littera, M., Papi, G., Sanna, E., Tuveri, F., Usala, L., Purdy, R.H., & Biggio, G., 2000, Social Isolation-Induced Decreases in Both the Abundance of Neuroactive Steroids and GABA A Receptor Function in Rat Brain.","DOI":"10.1046\/j.1471-4159.2000.0750732.x"},{"issue":"7","key":"10.1016\/j.neubiorev.2023.105327_bib166","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/ajp.2007.164.7.1029","article-title":"Suicide attempts among patients starting depression treatment with medications or psychotherapy","volume":"164","author":"Simon","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib167","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.psyneuen.2016.10.001","article-title":"Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens","volume":"74","author":"Soggiu","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neubiorev.2023.105327_bib168","doi-asserted-by":"crossref","unstructured":"Sripada, R.K., Marx, C.E., King, A.P., Rampton, J.C., Ho, S., & Liberzon, I., 2012, Allopregnanolone Elevations Following Pregnenolone Administration are Associated with Enhanced Activation of Emotion Regulation Neurocircuits. https:\/\/doi.org\/10.1016\/j.biopsych.2012.12.008.","DOI":"10.1016\/j.biopsych.2012.12.008"},{"issue":"4","key":"10.1016\/j.neubiorev.2023.105327_bib169","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1503\/jpn.110069","article-title":"Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder","volume":"37","author":"Sripada","year":"2012","journal-title":"J. Psychiatry Neurosci.: JPN"},{"issue":"7","key":"10.1016\/j.neubiorev.2023.105327_bib170","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1002\/hbm.22399","article-title":"The neurosteroids allopregnanolone and dehydroepiandrosterone modulate resting\u2010state amygdala connectivity","volume":"35","author":"Sripada","year":"2014","journal-title":"Hum. Brain Mapp."},{"issue":"7718","key":"10.1016\/j.neubiorev.2023.105327_bib171","first-page":"431","article-title":"Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration","volume":"339","author":"Stone","year":"2009","journal-title":"BMJ (Clin. Res. Ed. )"},{"key":"10.1016\/j.neubiorev.2023.105327_bib172","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1176\/appi.ajp.159.1.145","article-title":"GABA A Receptor-Modulating Neuroactive Steroid Composition in Patients With Panic Disorder Before and During Paroxetine Treatment","volume":"159","author":"Str\u00f6hle","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib173","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.60.2.161","article-title":"Induced Panic Attacks Shift \u03b3-Aminobutyric Acid Type A Receptor Modulatory Neuroactive Steroid Composition in Patients With Panic Disorder: Preliminary Results","volume":"60","author":"Str\u00f6hle","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib174","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archpsyc.60.2.133","article-title":"Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia","volume":"60","author":"Strous","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jad.2022.03.068","article-title":"Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder","volume":"308","author":"Suthoff","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.neubiorev.2023.105327_bib176","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1530\/eje.0.1510717","article-title":"A longitudinal study of dehydroepiandrosterone sulphate (DHEAS) change in older men and women: the Rancho Bernardo Study","volume":"151","author":"Tannenbaum","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.neubiorev.2023.105327_bib177","doi-asserted-by":"crossref","unstructured":"Tokuda, K., O\u2019dell, K.A., Izumi, Y., & Zorumski, C.F., 2010, Development\/Plasticity\/Repair Midazolam Inhibits Hippocampal Long-Term Potentiation and Learning through Dual Central and Peripheral Benzodiazepine Receptor Activation and Neurosteroidogenesis. https:\/\/doi.org\/10.1523\/JNEUROSCI.4101\u201310.2010.","DOI":"10.1523\/JNEUROSCI.4101-10.2010"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib178","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11154-015-9319-y","article-title":"Adverse effects of 5\u03b1-reductase inhibitors: What do we know, don\u2019t know, and need to know?","volume":"16","author":"Traish","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.neubiorev.2023.105327_bib179","first-page":"12599","article-title":"Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography","volume":"93","author":"Uzunov","year":"1996"},{"key":"10.1016\/j.neubiorev.2023.105327_bib180","article-title":"Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine","volume":"Vol. 95","author":"Uzunova","year":"1998","journal-title":"Neurobiology"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(03)02577-0","article-title":"Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression","volume":"976","author":"Uzunova","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2023.105327_bib182","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.mp.4002030","article-title":"Progesterone selectively increases amygdala reactivity in women","volume":"13","author":"Van Wingen","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib183","first-page":"11","article-title":"Lithium Treatment Over the Lifespan in Bipolar Disorders","author":"Volkmann","year":"2020","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib184","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1745-6916.2008.00059.x","article-title":"Schizophrenia","volume":"3","author":"Walker","year":"2008","journal-title":"Perspect. Psychol. Sci."},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/schbul\/20.3.453","article-title":"Developmental^ moderated expressions of the neuropathology underlying schizophrenia","volume":"20","author":"Walker","year":"1994","journal-title":"Schizophr. Bull."},{"issue":"12","key":"10.1016\/j.neubiorev.2023.105327_bib186","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/acer.13511","article-title":"Alcohol and stress activation of microglia and neurons: brain regional effects","volume":"41","author":"Walter","year":"2017","journal-title":"Alcohol.: Clin. Exp. Res."},{"key":"10.1016\/j.neubiorev.2023.105327_bib187","first-page":"11","article-title":"Allopregnanolone-based treatments for postpartum depression: Why\/how do they work","author":"Walton","year":"2019","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neubiorev.2023.105327_bib188","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2023.01.022","article-title":"Impaired endogenous neurosteroid signaling contributes to behavioral deficits associated with chronic stress","author":"Walton","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib189","first-page":"811076","article-title":"Relationship between Symptom Severity and Steroid Variation in Women with Premenstrual Syndrome: Study on Serum Pregnenolone, Pregnenoione Sulfate, k=Pregnane=3,20=Dione and 3cx-Hydroxy&u-Pregnan=20=One*","author":"Wang","year":"1996","journal-title":"J. Climeal Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(91)91658-N","article-title":"Anxiolytic activity of the progesterone metabolite 5 alpha-pregnan-3 alpha-o1-20-one","volume":"565","author":"Wieland","year":"1991","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00427414","article-title":"The validity of animal models of depression","volume":"83","author":"Willner","year":"1984","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib192","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0163-7258(90)90076-E","article-title":"Animal models of depression: an overview","volume":"45","author":"Willner","year":"1990","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib193","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0034-1398507","article-title":"Enhancing neurosteroid synthesis - Relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines","volume":"48","author":"Wolf","year":"2015","journal-title":"Pharmacopsychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib194","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0006-3223(96)00043-1","article-title":"Dehydroepiandrosterone (DHEA) treatment of depression","volume":"41","author":"Wolkowitz","year":"1997","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib195","doi-asserted-by":"crossref","unstructured":"Wolkowitz, O.M., Reus, V.I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E., 1999, Double-Blind Treatment of Major Depression With Dehydroepiandrosterone. Https:\/\/Doi.Org\/10.1176\/Ajp.156.4.646, 156(4), 646\u2013649. https:\/\/doi.org\/10.1176\/AJP.156.4.646.","DOI":"10.1176\/ajp.156.4.646"},{"key":"10.1016\/j.neubiorev.2023.105327_bib196","doi-asserted-by":"crossref","DOI":"10.1177\/24705470211029254","article-title":"Chronic stress weakens connectivity in the prefrontal cortex: architectural and molecular changes","volume":"5","author":"Woo","year":"2021","journal-title":"Chronic Stress"},{"issue":"3","key":"10.1016\/j.neubiorev.2023.105327_bib197","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jphs.2020.03.003","article-title":"Benzothiazepines, diltiazem and JTV-519, exert an anxiolytic-like effect via neurosteroid biosynthesis in mice","volume":"143","author":"Yoshizawa","year":"2020","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.neubiorev.2023.105327_bib198","doi-asserted-by":"crossref","first-page":"29169","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2023.105327_bib199","first-page":"183","article-title":"A neuroactive steroid with a therapeutically interesting constellation of actions at GABAA and NMDA receptors","author":"Ziolkowski","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neubiorev.2023.105327_bib200","first-page":"659","article-title":"Neurosteroids as therapeutic leads in psychiatry","volume":"Vol. 70","author":"Zorumski","year":"2013"},{"issue":"1","key":"10.1016\/j.neubiorev.2023.105327_bib201","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neubiorev.2012.10.005","article-title":"Neurosteroids, stress and depression: potential therapeutic opportunities","volume":"37","author":"Zorumski","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2023.105327_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100196","article-title":"Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond","volume":"11","author":"Zorumski","year":"2019","journal-title":"Neurobiol. Stress"}],"container-title":["Neuroscience &amp; Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423002968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763423002968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:50:22Z","timestamp":1758970222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763423002968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":202,"alternative-id":["S0149763423002968"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105327","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurosteroid influence on affective tone","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105327"}}